Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|June 8, 2026
Evaluating the investigational drug landscape for ESR1-mutated, estrogen receptor positive, HER2 negative metastatic breast cancerMarie Kroemer, Morgane Lopez, Laura Mansi, et al.Bulletin Du Cancer|June 21, 2011
[EGFR/HER1: a target life]Erika Viel, Elsa Curtit, Laura Mansi, et al.Bulletin Du Cancer|July 1, 2011
[Targeting the RAS signalling pathway in cancer]Laura Mansi, Erika Viel, Elsa Curtit, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Caroline Laheurte, Laura Mansi, et al.European Journal of Cancer (Oxford, England : 1990)|November 19, 2020
How to manage patients with corticosteroids in oncology in the era of immunotherapy?Mihaela Aldea, Emeline Orillard, Laura Mansi, et al.Bulletin Du Cancer|June 15, 2011
[KIT and KIT: from biology to clinical use]Elsa Curtit, Laura Mansi, Erika Viel, et al.Journal of Patient Safety|October 2, 2025
Missed Nursing Care in Nursing Homes and Causes: A Systematic ReviewSimone Cosmai, Valentina Trezzi, Laura Mansi, et al.Expert Opinion on Drug Safety|February 24, 2010
Safety profile of new anticancer drugsLaura Mansi, Antoine Thiery-Vuillemin, Thierry Nguyen, et al.International Journal of Cancer|September 6, 2018
Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacyLaurent Beziaud, Laura Boullerot, Thi Tran, et al.Bulletin Du Cancer|April 21, 2012
[Immunotherapy: an emerging strategies against prostate castration resistant cancer]Laura Mansi, Antoine Thiery-Vuillemin, Elsa Kalbacher, et al.Pageof 5